The SignalToday's digest →

The ‘Pathogen Hunters’ track microbes around the world. But are their data real?

Science · original · full text captured 16 November 2026 · WhatsApp · Email

The ‘Pathogen Hunters’ track microbes around the world. But are their data real? | Science | AAAS

Opens in a new window

Opens an external website

Opens an external website in a new window

<!---->Close this consent banner<!---->

We and our 3 IAB TCF partners store and access information on your device for the following purposes: store and/or access information on a device, advertising and content measurement, audience research, and services development, personalised advertising, and personalised content.

Personal data may be processed to do the following: use precise geolocation data and identify devices based on information actively requested.

Our third party IAB TCF partners may store and access information on your device such as IP address and device characteristics. Our IAB TCF Partners may process this personal data on the basis of legitimate interest, or with your consent. You may change or withdraw your preferences for this website at any time by clicking on the cookie icon or link; however, as a consequence, you may not see relevant ads or personalized content.

You may change your settings at any time or accept the default settings.

You may close this banner to continue with only essential cookies.

<!----><!---->

science translational medicine

Quick Search in Journals

Enter Search Term

Quick Search in Journals

Enter Search Term

Quick Search in Journals

Enter Search Term

Quick Search in Journals

Enter Search Term

Quick Search in Journals

Enter Search Term

Quick Search in Journals

Enter Search Term

Searching:

Science Translational Medicine

Advanced Search

science.org

science translational medicine

Main content starts here

ScienceInsider

Scientific Community

Exclusive: The ‘Pathogen Hunters’ track microbes around the world. But are their data real?

Critics question baffling genetic data from prolific infectious diseases group

Sooty gulls perch on rocks on the island of Socotra in Yemen, one of 10 countries where Pathogen Hunters claims it collected guano for an avian influenza study.

Chuck David/VWPics via AP Images

Share:

A version of this story appeared in Science, Vol 394, Issue 6825.

Download PDF

Go ten seconds backward

Skip forwards

Go ten seconds forward

Progress

1.0x

Mute

Unmute

Volume is at 50%

00:00

1.0x

Audio is AI-generated.

In May 2025, a paper in

Nature Communications

made a startling claim about avian influenza viruses found in guano from Africa, the Middle East, Asia, and Oceania. Genetic sequences of some viruses were identical to those of strains found years earlier, in distant locales, claimed the authors, a group that calls itself

Pathogen Hunters

and is led by Dhammika Leshan Wannigama of Yamagata University in Japan.

The finding challenged scientists’ understanding of flu virus evolution, calling into question risk assessments and policies meant to protect livestock and humans. To skeptics, however, the claim was highly implausible, because flu viral RNA is always changing.

Last week,

airing the skeptics’ doubts. The study had “widespread sequencing errors” that could lead to “misleading conclusions,” 13 flu researchers wrote in a peer-reviewed commentary. An accompanying

rebuttal

from Pathogen Hunters said it had fixed the problems, but that didn’t satisfy the critics. “All our concerns still stand,” says Michelle Wille, a wildlife ecologist at the University of Melbourne who specializes in avian influenza and spearheaded the critique.

SCIENCE

ADVISER NEWSLETTER

The latest news, commentary, and research, free to your inbox daily

It’s not the only paper by Pathogen Hunters that has come under criticism. Over the past 4 years, the group has published dozens of eye-catching studies for which it claims to have collected more than 60,000 samples in 38 countries, including

war-torn nations

such as Yemen, Somalia, and Sudan. It has sampled wastewater from 11 countries to look for

SARS-CoV-2

; tested discarded

condoms

from brothels and public restrooms for the mpox virus; and found a tapeworm that sickens humans in feces from

wild bears

. Critics question how the group could have collected so many samples in such a short period, and they have found anomalies in the genomic data of at least five papers.

“It all just seemed weird that one group could possibly be doing this,” says Paul Sharp, a semiretired evolutionary biologist at the University of Edinburgh. Like some other critics, he suspects misconduct. “When you dig into more detail about the data they’ve produced, it’s bogus.” Sharp’s analyses led

The Journal of Infectious Diseases

(

JID

) to retract one paper and add an “expression of concern” to another. Wannigama and co-authors have published substantive corrections to the

bird flu study

and one on

COVID-19 monitoring

.

The many complaints about Wannigama’s work led Yamagata University in May to launch an

investigation

into “research integrity matters.” In response to questions from

Science

, Wannigama said he wanted to wait for its outcomes “out of respect for that ongoing administrative process, and in compliance with strict institutional data privacy policies.” A university administrator says the investigation “does not include any of Dr. Wannigama’s collaborators.” The school hopes to reach a final conclusion next month.

Originally from Sri Lanka, Wannigama, 40, obtained a

Ph.D.

at Chulalongkorn University in Thailand in 2019. He has listed an affiliation with the University of Western Australia on several papers, but the school told

Science

he was “an international student who enrolled in a postgraduate course … in 2018 but did not complete it.”

Pathogen Hunters says it’s on “a mission to stop the world’s deadliest threats.” Its website features Wannigama and 15 main investigators, most of them based in Japan and Thailand, with 24 collaborators in 20 other countries. (After this story appeared, Pathogen Hunters took down its website and posted  a “Site Under Maintenance” notice, but

Science

saved the site on the

Wayback Machine

on 10 November.) Its primary funders include a cryptocurrency philanthropist and two personal “memorial” funds. Since launching Pathogen Hunters in 2022, Wannigama has published more than 70 papers.

The first warning of trouble came in 2024, after Pathogen Hunters published results from a large clinical trial in

eClinicalMedicine

showing that four cheap drugs used for other diseases also worked for COVID-19. On

PubPeer

, a forum for commenting on published studies, Mathieu Molimard, a pharmacologist from the University of Bordeaux, wrote that the treatments lacked “a plausible pharmacological basis,” data were missing, and the findings contradicted those from other “well-conducted clinical trials,” which together “completely undermine” the paper.

The

Nature Communications

paper caused more consternation. Pathogen Hunters reported that H5N1 viruses from 2021 and ’22 in Papua New Guinea, Indonesia, and Sri Lanka had sequences that exactly matched viruses found as many as 14 years earlier. More startling still, an H7 variant that surfaced in Australian poultry in 2020 but was eliminated by culling nearly half a million birds—and was never found in wild birds—showed up in those three countries and in the Maldives and Mozambique, implying it threatened poultry there. An H5 strain in Yemen and Somalia was highly similar to one only found in U.S. dairy herds. “It doesn’t make any sense,” Wille says.

“At first we gave them the benefit of the doubt, thinking these were just nonflu researchers who got in a little over their heads,” says a co-author on the critique who did not have permission from their employer to speak publicly. “But they were very squirrely about it with lots of excuses and very cryptic communications.” The critics also noted the study didn’t mention ethics approvals or permits to collect, export, and import avian-derived samples.

In its published reply, Wannigama’s team noted it sampled rarely surveyed locales and cautioned “against assuming that certain transmission patterns are impossible.” The researchers maintained their conclusions were based on the correct sequences, but said they accidentally submitted erroneous ones to a database called GISIAD, and had uploaded corrected sequences. The work “received ethical exemption approval from our institute in Japan,” they wrote, and the team “carefully confirmed with the relevant local authorities that no special permits were required for the type of environmental fecal waste sampling undertaken in this study.”

Since launching Pathogen Hunters in 2022, Dhammika Leshan Wannigama has published more than 70 papers.

Pathogenhunters.com

The corrected sequences only raise new questions, says Richard Neher, a computational biologist at the University of Basel who had criticized the original paper on

PubPeer

. “A couple of sequences were removed that were the most implausible, and there are little mutations in these data now that make these sequences unique,” Neher says. But in several cases only a single nucleotide was changed, and sometimes the changes don’t conform with expected mutation patterns. “This is very, very odd,” Neher says. “I don’t think these are genuine samples.”

Erik Karlsson, head virologist at the Pasteur Institute of Cambodia and co-author of the critique in

Nature Communications

, doesn’t buy the contention that the team had proper permits. “Most of the countries on their list have a law or ordinance about sharing biological materials,” he says.

Wille says

Nature Communications

should retract the paper and is baffled that it took 15 months to publish the criticism. “I just don’t understand what more they need,” she says. “This is a massive failure on the part of

Nature Communications

.” Ripudaman Bains, an editor at the journal, told

Science

the process included “engaging independent expert review of the [critique], the Reply, and the updated sequence data” and was completed as “swiftly and efficiently as possible.” The journal is “satisfied that the paper complies with our editorial policies including ethics policies,” Bains wrote.

More odd data

arrived in a March

, a malaria parasite that infects monkeys in Asia and spills over to humans. The team said it had tested 4752 macaque fecal samples collected in nine countries and found the parasite in 8.2% of them. Previous studies mostly relied on trapping wild monkeys and bleeding them to assess

P. knowlesi

prevalence, but the researchers said fecal sampling was a “scalable, ethical, and field-adaptable” alternative.

The finding excited Richard Culleton, a parasitologist at Ehime University who had attempted wild monkey fecal sampling for

P. knowlesi

but found it produced too many false-negative results. “Reading your paper has given us new hope!” he emailed Wannigama, asking how the team had collected samples, processed them, and obtained proper permissions.

Then he learned the team had not tested monkey blood to confirm the fecal findings; its philanthropic funders, Wannigama said, were “not comfortable” with invasive animal studies. That meant the assertion that monkey feces could be used to track the parasite was “wrong, and may confuse those of us working in the field,” he wrote to Wannigama.

Sharp, who collaborates with Culleton, found another warning sign when he examined the study’s

P. knowlesi

sequences in a public database called GenBank. The 387 entries only contained 33 unique sequences—and each one was already in GenBank before the Wannigama team’s upload. As he dug deeper, Sharp found more problems. “It’s not errors,” he says. “It’s fraud.” He notified

JID

, which retracted the paper in July, noting the authors “confirmed that they were unable to fully retrieve and verify the original raw sequencing files and associated metadata.”

Sharp found similar problems in a

JID

paper by the group on

Streptococcus pyogenes

and toxic shock, leading the journal to issue an “

expression of concern

” while it investigates that complaint. And Neher compiled detailed critiques of papers by Pathogen Hunters on mpox and two bacteria,

, which he shared with

Science

. “Whichever paper you look at, there seem to be issues,” he says.

The doubts extend

beyond research data

. Wannigama has signed emails to Culleton and Neher with “MD” after his name, but he didn’t mention the degree on a 2019 CV.

Science

found he was not listed in medical registries in Japan, Thailand, India, or Sri Lanka. Several of his papers credit local “LGBTQIA+ communities” with help collecting samples, but no individuals or specific groups are named, and it’s unclear why they would help collect bird guano or monkey feces for diseases that have no particular link to those lesbian, gay, bisexual, or transgender communities. “It’s a red flag when it keeps coming up in papers where it doesn’t belong,” says Joel Wertheim, an evolutionary biologist at the University of California San Diego.

The criticisms of Wannigama’s work also raise questions about the role of his dozens of co-authors.

Science

emailed 15 co-authors who appear on some or all of the six studies that have come under criticism. Ten did not respond. The other five said they were embarrassed by their involvement but contributed relatively little to the papers. Jonas Bonnedahl, an infectious disease clinician in Sweden who specializes in antimicrobial resistance and bird migration, said he was surprised Wannigama offered to make him a co-author on the

Nature Communications

paper. “I had two digital meetings with him about bird movement, and my input in the paper is not so much,” he says. Bonnedahl says he thought he was helping an early-career researcher but now feels “almost abused.”

A co-author on the retracted

P. knowlesi

paper, infectious disease clinician Ng Sin Hui at the University of Malaya Medical Centre, says he only commented on the manuscript and knew nothing about sample collection, ethical approval, or permits. “I should have sought more detailed clarification regarding certain methodological and regulatory aspects of the work,” Ng says. He says he met Wannigama just once, at a conference, and like other co-authors, contends Wannigama included him to bolster his credibility.

One co-author who asked not to be identified blames himself for not noticing that the supplement of a paper about SARS-CoV-2 in wastewater had five identical figures. That paper has been corrected, but Wannigama’s attitude about the problem bothered him. “Editors told me they don’t much care and we can correct the graph,” Wannigama wrote his co-author. “I am okay with people showing our mistakes.”

Unreliable data have real-world consequences, the critics stress. An mpox paper by Pathogen Hunters contained “shocking” claims and upended previous findings about viral evolution and spread, Wertheim says. Asserting that a dangerous bird flu variant circulates in a country “has really, really big ramifications,” Wille adds. And erroneous sequences in databases can lead to inaccurate family trees, confusing drug and vaccine developers. “We’re trying to solve public health problems,” Culleton says, “and this is just making our jobs more difficult.”

Correction, 11 November, 2:35 p.m.:

A previous version of this story said the birds in the photo at the top were shearwaters, as indicated in a caption provided by AP Images. They are actually sooty gulls.

doi: 10.1126/science.zxasfav

Relevant tags:

Jon Cohen, senior correspondent with

Science

, earned his B.A. in science writing from the University of California San Diego. He can be reached on Signal at

bval31.65 and on Bluesky at @cohenjon.bsky.social.

View more

10 Nov 2026

Can researchers bring order to the confusing world of AI ‘benchmarks’?

By

Ananya

9 Nov 2026

To deter bioterrorism, U.S. imposes new rules on ordering synthetic DNA

By

Phie Jacobs

9 Nov 2026

Researchers sue to block NSF from demolishing social science directorate

Got a tip for Science's news department?

Connect

Get

Science

’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily.

10 Nov 2026

By

Ananya

Can researchers bring order to the confusing world of AI ‘benchmarks’?

9 Nov 2026

By

Phie Jacobs

To deter bioterrorism, U.S. imposes new rules on ordering synthetic DNA

9 Nov 2026

By

Daniel Garisto

Researchers sue to block NSF from demolishing social science directorate

9 Nov 2026

By

Jeffrey Brainard

AI beats scientists at finding errors in clinical research papers

9 Oct 2026

By

Julia Vaz

Trump administration proposes $100,000 fee for work authorization for international students

6 Oct 2026

By

Taylor Mitchell Brown

Exclusive: Archaeology megafirm abruptly shuts down

4 Sep 2026

By

John Travis

Gene-edited pig kidney transplant sets record—and offers bridge to human organs

18 Aug 2026

By

Phie Jacobs

FDA pick is Heidi Overton

17 Mar 2023

By

Jocelyn Kaiser

Growing number of high-security pathogen labs around world raises concerns

News of the Week

May 2014

Around the World

News of the Week

November 2013

Around the World

News of the Week

December 2013

21 Oct 2026

Battle for the gut: From microbial competition to therapeutic communities

×

$50

$75

$100

Other

$

Please enter a valid amount

Single

Monthly

Email:

Please enter a valid email

Country:

Bolivia, Plurinational State of

Bonaire, Sint Eustatius and Saba

British Indian Ocean Territory

Congo, The Democratic Republic of the

Cook Islands

Costa Rica

Cote D'Ivoire

Falkland Islands (Malvinas)

French Southern Territories

Heard Island and Mcdonald Islands

Holy See (Vatican City State)

Iran, Islamic Republic of

Korea, Democratic People's Republic of

Korea, Republic of

Kuwait

Kyrgyzstan

Lao People's Democratic Republic

Macedonia, The Former Yugoslav Republic of

Moldova, Republic of

Saint Helena, Ascension and Tristan da Cunha

Saint Kitts and Nevis

Saint Lucia

Saint Martin (French part)

Saint Pierre and Miquelon

Saint Vincent and the Grenadines

Samoa

San Marino

Sao Tome and Principe

Sint Maarten (Dutch part)

South Georgia and the South Sandwich Islands

Svalbard and Jan Mayen

Tanzania, United Republic of

Turks and Caicos Islands

Venezuela, Bolivarian Republic of

Vietnam

Virgin Islands, British

also wish to receive emails from AAAS/Science and Science advertisers,

including information on products, services and special offers which may

include but are not limited to news, careers information & upcoming

events.

Support nonprofit science journalism

Amid the unprecedented upheaval in U.S. science, hard-hitting, trustworthy reporting has never been more important. As part of the AAAS mission,

Science

has built a global award-winning network of reporters and editors that independently cover the most important developments in research and policy.

Your tax-deductible contribution plays a critical role in sustaining this effort.

If, at any time, you would like to stop or make changes to your monthly gift, please contact the Philanthropy Office at

philanthropy@aaas.org

or 202-326-6636.

Charitable Disclosures

Loading...

×

Support nonprofit science journalism

Help News from

Science

publish trustworthy, high-impact stories about research and the people who shape it.

Please make a tax‑deductible gift today.

Thanks for sharing!